130 related articles for article (PubMed ID: 9391904)
1. Adolescent girls' understanding of Papanicolaou smear results.
Biro FM; Rosenthal SL; Rymarquis L; Kollar LM; Hillard PJ
J Pediatr Adolesc Gynecol; 1997 Nov; 10(4):209-12. PubMed ID: 9391904
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of genital human papillomavirus infection in a female adolescent population.
Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing human papillomavirus of the female lower genital tract: failure of the Pap smear as a sole screening test.
Lonky NM; Mahoney A; Sauer MV
J Gynecol Surg; 1991; 7(3):183-9. PubMed ID: 10150073
[TBL] [Abstract][Full Text] [Related]
4. Detection of human papillomavirus in cervical biopsies of summer camp ROTC cadets with abnormal papanicolaou smears.
Stafford EM; Stewart RS; Teague GR; Gomez RR; Crothers BA; Michel TJ; Patience TH; Moore DC
J Pediatr Adolesc Gynecol; 1996 Aug; 9(3):119-24. PubMed ID: 8795786
[TBL] [Abstract][Full Text] [Related]
5. Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the Former Soviet Union.
Syrjänen S; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grunberga V; Grunberg A; Juschenko A; Tosi P; Cintorino M; Santopietro R; Syrjänen K
J Clin Microbiol; 2004 Feb; 42(2):505-11. PubMed ID: 14766808
[TBL] [Abstract][Full Text] [Related]
6. Testing for human papillomavirus in women with abnormal pap smear results.
McCaffery KJ; Waller J; Forrest S; Wardle J
JAMA; 2002 Sep; 288(11):1350; author reply 1351-2. PubMed ID: 12234219
[No Abstract] [Full Text] [Related]
7. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
8. [Papillomaviruses and herpesviruses as selected risk factors in the etiopathogenesis of cervix neck cancer. I. Use of nucleic acid hybridization for diagnosing HPV infections].
Szkoda MT; Rekosz M; Litwińska B; Kańtoch M
Med Dosw Mikrobiol; 1999; 51(3-4):383-92. PubMed ID: 10803268
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Human Papillomavirus Genotypes and Abnormal Pap Smears Among Women in the Military Health System.
Daly CM; Hansen SL; Kwon PO; Roberts TA
J Community Health; 2018 Jun; 43(3):441-447. PubMed ID: 29168085
[TBL] [Abstract][Full Text] [Related]
10. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention.
Moreira ED; Oliveira BG; Ferraz FM; Costa S; Costa Filho JO; Karic G
Int J Gynecol Cancer; 2006; 16(2):599-603. PubMed ID: 16681732
[TBL] [Abstract][Full Text] [Related]
11. HPV for cervical cancer screening: is the era of the molecular pap smear upon us?
Stoler MH
J Histochem Cytochem; 2001 Sep; 49(9):1197-8. PubMed ID: 11511693
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic.
Lavin C; Goodman E; Perlman S; Kelly LS; Emans SJ
J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):141-5. PubMed ID: 9288658
[TBL] [Abstract][Full Text] [Related]
13. The association between cervical inflammation and histologic evidence of HPV in PAP smears and adverse pregnancy outcome in low risk population.
Nimrodi M; Kleitman V; Wainstock T; Gemer O; Meirovitz M; Maymon E; Benshalom-Tirosh N; Erez O
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():160-165. PubMed ID: 29727786
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of hybrid capture HPV DNA assay as a diagnostic tool for human papillomavirus infection.
Kubota T; Ishi K; Suzuki M; Utsuno S; Igari J
Kansenshogaku Zasshi; 1998 Nov; 72(11):1219-24. PubMed ID: 9884509
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer, Pap smear and HPV testing: an update of the role of organized Pap smear screening and HPV testing.
Sigurdsson K
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):467-77. PubMed ID: 10376855
[No Abstract] [Full Text] [Related]
17. Human papillomavirus absence predicts normal cervical histopathologic findings with abnormal papanicolaou smears: a study of a university-based inner city population.
Khanna N; Brooks SE; Chen TT; Simsir A; Gordon NJ; Taylor G
J Hum Virol; 2001; 4(5):283-7. PubMed ID: 11907386
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear.
Blumenthal PD; Gaffikin L; Chirenje ZM; McGrath J; Womack S; Shah K
Int J Gynaecol Obstet; 2001 Jan; 72(1):47-53. PubMed ID: 11146077
[TBL] [Abstract][Full Text] [Related]
19. HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.
Apgar BS; Brotzman G
Am Fam Physician; 1999 May; 59(10):2794-801. PubMed ID: 10348071
[TBL] [Abstract][Full Text] [Related]
20. Pap smear screening in an urban STD clinic. Yield of screening and predictors of abnormalities.
Shlay JC; McGill WL; Masloboeva HA; Douglas JM
Sex Transm Dis; 1998 Oct; 25(9):468-75. PubMed ID: 9800258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
